Age Related Macular Degeneration Drug Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: A0C5311D4E6CEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Age Related Macular Degeneration Drug in global, including the following market information:

Global Age Related Macular Degeneration Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Age Related Macular Degeneration Drug Market Sales, 2016-2021, 2022-2027, (K Units)

Global top five Age Related Macular Degeneration Drug companies in 2020 (%)

The global Age Related Macular Degeneration Drug market was valued at 7505.3 million in 2020 and is projected to reach US$ 9349.4 million by 2027, at a CAGR of 5.6% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Age Related Macular Degeneration Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Age Related Macular Degeneration Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Age Related Macular Degeneration Drug Market Segment Percentages, By Type, 2020 (%)

• Lucentis
• Eylea
• Avastin
• Others

Global Age Related Macular Degeneration Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Age Related Macular Degeneration Drug Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Clinics
• Others

Global Age Related Macular Degeneration Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)

Global Age Related Macular Degeneration Drug Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Age Related Macular Degeneration Drug revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Age Related Macular Degeneration Drug revenues share in global market, 2020 (%)

Key companies Age Related Macular Degeneration Drug sales in global market, 2016-2021 (Estimated), (K Units)

Key companies Age Related Macular Degeneration Drug sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Regeneron Pharmaceuticals
• Bayer HealthCare
• Novartis
• Roche
• Kanghong Pharma

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Age Related Macular Degeneration Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Age Related Macular Degeneration Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG OVERALL MARKET SIZE

2.1 Global Age Related Macular Degeneration Drug Market Size: 2021 VS 2027
2.2 Global Age Related Macular Degeneration Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Age Related Macular Degeneration Drug Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Age Related Macular Degeneration Drug Players in Global Market
3.2 Top Global Age Related Macular Degeneration Drug Companies Ranked by Revenue
3.3 Global Age Related Macular Degeneration Drug Revenue by Companies
3.4 Global Age Related Macular Degeneration Drug Sales by Companies
3.5 Global Age Related Macular Degeneration Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Age Related Macular Degeneration Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Age Related Macular Degeneration Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Age Related Macular Degeneration Drug Players in Global Market
  3.8.1 List of Global Tier 1 Age Related Macular Degeneration Drug Companies
  3.8.2 List of Global Tier 2 and Tier 3 Age Related Macular Degeneration Drug Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Age Related Macular Degeneration Drug Market Size Markets, 2021 & 2027
  4.1.2 Lucentis
  4.1.3 Eylea
  4.1.4 Avastin
  4.1.5 Others
4.2 By Type - Global Age Related Macular Degeneration Drug Revenue & Forecasts
  4.2.1 By Type - Global Age Related Macular Degeneration Drug Revenue, 2016-2021
  4.2.2 By Type - Global Age Related Macular Degeneration Drug Revenue, 2022-2027
  4.2.3 By Type - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Age Related Macular Degeneration Drug Sales & Forecasts
  4.3.1 By Type - Global Age Related Macular Degeneration Drug Sales, 2016-2021
  4.3.2 By Type - Global Age Related Macular Degeneration Drug Sales, 2022-2027
  4.3.3 By Type - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
4.4 By Type - Global Age Related Macular Degeneration Drug Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Age Related Macular Degeneration Drug Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Others
5.2 By Application - Global Age Related Macular Degeneration Drug Revenue & Forecasts
  5.2.1 By Application - Global Age Related Macular Degeneration Drug Revenue, 2016-2021
  5.2.2 By Application - Global Age Related Macular Degeneration Drug Revenue, 2022-2027
  5.2.3 By Application - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Age Related Macular Degeneration Drug Sales & Forecasts
  5.3.1 By Application - Global Age Related Macular Degeneration Drug Sales, 2016-2021
  5.3.2 By Application - Global Age Related Macular Degeneration Drug Sales, 2022-2027
  5.3.3 By Application - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
5.4 By Application - Global Age Related Macular Degeneration Drug Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Age Related Macular Degeneration Drug Market Size, 2021 & 2027
6.2 By Region - Global Age Related Macular Degeneration Drug Revenue & Forecasts
  6.2.1 By Region - Global Age Related Macular Degeneration Drug Revenue, 2016-2021
  6.2.2 By Region - Global Age Related Macular Degeneration Drug Revenue, 2022-2027
  6.2.3 By Region - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Age Related Macular Degeneration Drug Sales & Forecasts
  6.3.1 By Region - Global Age Related Macular Degeneration Drug Sales, 2016-2021
  6.3.2 By Region - Global Age Related Macular Degeneration Drug Sales, 2022-2027
  6.3.3 By Region - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Age Related Macular Degeneration Drug Revenue, 2016-2027
  6.4.2 By Country - North America Age Related Macular Degeneration Drug Sales, 2016-2027
  6.4.3 US Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.4.4 Canada Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.4.5 Mexico Age Related Macular Degeneration Drug Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Age Related Macular Degeneration Drug Revenue, 2016-2027
  6.5.2 By Country - Europe Age Related Macular Degeneration Drug Sales, 2016-2027
  6.5.3 Germany Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.4 France Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.5 U.K. Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.6 Italy Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.7 Russia Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.8 Nordic Countries Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.5.9 Benelux Age Related Macular Degeneration Drug Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Age Related Macular Degeneration Drug Revenue, 2016-2027
  6.6.2 By Region - Asia Age Related Macular Degeneration Drug Sales, 2016-2027
  6.6.3 China Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.6.4 Japan Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.6.5 South Korea Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.6.6 Southeast Asia Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.6.7 India Age Related Macular Degeneration Drug Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Age Related Macular Degeneration Drug Revenue, 2016-2027
  6.7.2 By Country - South America Age Related Macular Degeneration Drug Sales, 2016-2027
  6.7.3 Brazil Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.7.4 Argentina Age Related Macular Degeneration Drug Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Age Related Macular Degeneration Drug Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Age Related Macular Degeneration Drug Sales, 2016-2027
  6.8.3 Turkey Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.8.4 Israel Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.8.5 Saudi Arabia Age Related Macular Degeneration Drug Market Size, 2016-2027
  6.8.6 UAE Age Related Macular Degeneration Drug Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 Regeneron Pharmaceuticals
  7.1.1 Regeneron Pharmaceuticals Corporate Summary
  7.1.2 Regeneron Pharmaceuticals Business Overview
  7.1.3 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Major Product Offerings
  7.1.4 Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales and Revenue in Global (2016-2021)
  7.1.5 Regeneron Pharmaceuticals Key News
7.2 Bayer HealthCare
  7.2.1 Bayer HealthCare Corporate Summary
  7.2.2 Bayer HealthCare Business Overview
  7.2.3 Bayer HealthCare Age Related Macular Degeneration Drug Major Product Offerings
  7.2.4 Bayer HealthCare Age Related Macular Degeneration Drug Sales and Revenue in Global (2016-2021)
  7.2.5 Bayer HealthCare Key News
7.3 Novartis
  7.3.1 Novartis Corporate Summary
  7.3.2 Novartis Business Overview
  7.3.3 Novartis Age Related Macular Degeneration Drug Major Product Offerings
  7.3.4 Novartis Age Related Macular Degeneration Drug Sales and Revenue in Global (2016-2021)
  7.3.5 Novartis Key News
7.4 Roche
  7.4.1 Roche Corporate Summary
  7.4.2 Roche Business Overview
  7.4.3 Roche Age Related Macular Degeneration Drug Major Product Offerings
  7.4.4 Roche Age Related Macular Degeneration Drug Sales and Revenue in Global (2016-2021)
  7.4.5 Roche Key News
7.5 Kanghong Pharma
  7.5.1 Kanghong Pharma Corporate Summary
  7.5.2 Kanghong Pharma Business Overview
  7.5.3 Kanghong Pharma Age Related Macular Degeneration Drug Major Product Offerings
  7.5.4 Kanghong Pharma Age Related Macular Degeneration Drug Sales and Revenue in Global (2016-2021)
  7.5.5 Kanghong Pharma Key News

8 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG PRODUCTION CAPACITY, ANALYSIS

8.1 Global Age Related Macular Degeneration Drug Production Capacity, 2016-2027
8.2 Age Related Macular Degeneration Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Age Related Macular Degeneration Drug Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 AGE RELATED MACULAR DEGENERATION DRUG SUPPLY CHAIN ANALYSIS

10.1 Age Related Macular Degeneration Drug Industry Value Chain
10.2 Age Related Macular Degeneration Drug Upstream Market
10.3 Age Related Macular Degeneration Drug Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Age Related Macular Degeneration Drug Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Age Related Macular Degeneration Drug in Global Market
Table 2. Top Age Related Macular Degeneration Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Age Related Macular Degeneration Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Age Related Macular Degeneration Drug Revenue Share by Companies, 2016-2021
Table 5. Global Age Related Macular Degeneration Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Age Related Macular Degeneration Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Age Related Macular Degeneration Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Age Related Macular Degeneration Drug Product Type
Table 9. List of Global Tier 1 Age Related Macular Degeneration Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Age Related Macular Degeneration Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Age Related Macular Degeneration Drug Sales (K Units), 2016-2021
Table 15. By Type - Global Age Related Macular Degeneration Drug Sales (K Units), 2022-2027
Table 16. By Application – Global Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Age Related Macular Degeneration Drug Sales (K Units), 2016-2021
Table 20. By Application - Global Age Related Macular Degeneration Drug Sales (K Units), 2022-2027
Table 21. By Region – Global Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Age Related Macular Degeneration Drug Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Age Related Macular Degeneration Drug Sales (K Units), 2016-2021
Table 25. By Region - Global Age Related Macular Degeneration Drug Sales (K Units), 2022-2027
Table 26. By Country - North America Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Age Related Macular Degeneration Drug Sales, (K Units), 2016-2021
Table 29. By Country - North America Age Related Macular Degeneration Drug Sales, (K Units), 2022-2027
Table 30. By Country - Europe Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Age Related Macular Degeneration Drug Sales, (K Units), 2016-2021
Table 33. By Country - Europe Age Related Macular Degeneration Drug Sales, (K Units), 2022-2027
Table 34. By Region - Asia Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Age Related Macular Degeneration Drug Sales, (K Units), 2016-2021
Table 37. By Region - Asia Age Related Macular Degeneration Drug Sales, (K Units), 2022-2027
Table 38. By Country - South America Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Age Related Macular Degeneration Drug Sales, (K Units), 2016-2021
Table 41. By Country - South America Age Related Macular Degeneration Drug Sales, (K Units), 2022-2027
Table 42. By Country - Middle East & Africa Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Age Related Macular Degeneration Drug Sales, (K Units), 2016-2021
Table 45. By Country - Middle East & Africa Age Related Macular Degeneration Drug Sales, (K Units), 2022-2027
Table 46. Regeneron Pharmaceuticals Corporate Summary
Table 47. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Product Offerings
Table 48. Regeneron Pharmaceuticals Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 49. Bayer HealthCare Corporate Summary
Table 50. Bayer HealthCare Age Related Macular Degeneration Drug Product Offerings
Table 51. Bayer HealthCare Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 52. Novartis Corporate Summary
Table 53. Novartis Age Related Macular Degeneration Drug Product Offerings
Table 54. Novartis Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 55. Roche Corporate Summary
Table 56. Roche Age Related Macular Degeneration Drug Product Offerings
Table 57. Roche Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 58. Kanghong Pharma Corporate Summary
Table 59. Kanghong Pharma Age Related Macular Degeneration Drug Product Offerings
Table 60. Kanghong Pharma Age Related Macular Degeneration Drug Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2016-2021)
Table 61. Age Related Macular Degeneration Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2019-2021 (K Units)
Table 62. Global Age Related Macular Degeneration Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 63. Global Age Related Macular Degeneration Drug Production by Region, 2016-2021 (K Units)
Table 64. Global Age Related Macular Degeneration Drug Production by Region, 2022-2027 (K Units)
Table 65. Age Related Macular Degeneration Drug Market Opportunities & Trends in Global Market
Table 66. Age Related Macular Degeneration Drug Market Drivers in Global Market
Table 67. Age Related Macular Degeneration Drug Market Restraints in Global Market
Table 68. Age Related Macular Degeneration Drug Raw Materials
Table 69. Age Related Macular Degeneration Drug Raw Materials Suppliers in Global Market
Table 70. Typical Age Related Macular Degeneration Drug Downstream
Table 71. Age Related Macular Degeneration Drug Downstream Clients in Global Market
Table 72. Age Related Macular Degeneration Drug Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Age Related Macular Degeneration Drug Segment by Type
Figure 2. Age Related Macular Degeneration Drug Segment by Application
Figure 3. Global Age Related Macular Degeneration Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Age Related Macular Degeneration Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Age Related Macular Degeneration Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Age Related Macular Degeneration Drug Sales in Global Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Age Related Macular Degeneration Drug Revenue in 2020
Figure 9. By Type - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 10. By Type - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 11. By Type - Global Age Related Macular Degeneration Drug Price (USD/Unit), 2016-2027
Figure 12. By Application - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 13. By Application - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 14. By Application - Global Age Related Macular Degeneration Drug Price (USD/Unit), 2016-2027
Figure 15. By Region - Global Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 16. By Region - Global Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 17. By Country - North America Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 18. By Country - North America Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 19. US Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 24. Germany Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 25. France Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 33. China Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 37. India Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 39. By Country - South America Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 40. Brazil Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Age Related Macular Degeneration Drug Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Age Related Macular Degeneration Drug Sales Market Share, 2016-2027
Figure 44. Turkey Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Age Related Macular Degeneration Drug Revenue, (US$, Mn), 2016-2027
Figure 48. Global Age Related Macular Degeneration Drug Production Capacity (K Units), 2016-2027
Figure 49. The Percentage of Production Age Related Macular Degeneration Drug by Region, 2020 VS 2027
Figure 50. Age Related Macular Degeneration Drug Industry Value Chain
Figure 51. Marketing Channels